세계의 펩티드 마이크로어레이 시장 규모 조사 및 예측 : 유형별 애플리케이션별, 최종 사용자별, 지역별 분석(2022-2029년)

Global Peptide Microarray Market is valued at approximately USD 761.42 million in 2021 and is anticipated to grow with a healthy growth rate of more than 4.20% over the forecast period 2022-2029. In the field of proteomics and clinical testing, peptide microarrays are a reliable approach that can monitor the function of protein linkages, histone-modifying enzymes, and binding activity on a wide scale. It can be used for in-vitro diagnostic tests, diagnostics, and vaccine development to identify IgG and IgM antibody responses on the epitope level in patient samples. The Peptide Microarray market is expanding because of factors such as rising diabetes and prevalence of chronic diseases, and technological advancements in diagnostic testing. However, reimbursement issues may halt market growth.

One of the chronic conditions with the fastest rate of development is diabetes. It has gotten more frequent during the last few decades. According to the World Health Organization, 537 million people have diabetes worldwide in 2021, with one in ten having more than one type of the disease. Chronic diseases are also more prone to emerge in older and obese populations. According to the World Bank Group, there were 727 million senior people on the earth in 2020; by 2050, that number is expected to quadruple to 1.5 billion.. The United States Food and Drug Administration revised its definition of a biologic on February 21, 2020, to include chemically synthesised polypeptides with a length of at least 40 amino acids but no more than 100 amino acids (synthetic proteins) and synthetic peptides with no more than 40 amino acids. Therefore, it is anticipated that the reasons will fuel market expansion going forward. In addition, rising adoption of Peptide Microarrays is creating lucrative growth in the market. However, the high cost of Peptide Microarray stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Peptide Microarray Market study include: Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for biosimilar development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

• Pepperprint Gmbh
• Raybiotech Life, Inc.
• Creative Biolabs
• Aurora Instruments Ltd.
• Kinexus Bioinformatics Corporation
• Bio-Synthesis
• Microarrays Inc.
• Bio-Rad Laboratories
• Jpt Peptide Technologies
• Merck Kgaa

Recent Developments in the Market:

• In June 2022, with a EUR 25 million Series A financing round, Ariceum Therapeutics began developing its star product, Satoreotide, for the management of both low- and high-grade neuroendocrine tumours.
• In May 2022, Pfizer Inc. announced the acquisition of Biohaven Pharmaceutical Holding Company Ltd, the manufacturer of the ground-breaking dual-acting migraine treatment NURTEC ODT, which is approved for both episodic prevention and acute treatment of migraine in adults.

Global Peptide Microarray Market Report Scope:

• Historical Data: 2019-2020-2021

• Base Year for Estimation: 2021

• Forecast period: 2022-2029

• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

• Segments Covered: Type, Application, End-User, Region

• Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Typeofferings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

• Instruments
• Reagents
• Services

By Application:

• Disease Diagnostics
• Protein Functional Analysis
• Antibody Characterization
• Drug discovery

By End-User:

• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinics
• Diagnostic Centers
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
  • 1.2.1. Peptide Microarray Market, by Region, 2019-2029 (USD Million)
  • 1.2.2. Peptide Microarray Market, by Type, 2019-2029 (USD Million)
  • 1.2.3. Peptide Microarray Market, by Application, 2019-2029 (USD Million)
  • 1.2.4. Peptide Microarray Market, by End-Userre, 2019-2029 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Peptide Microarray Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Peptide Microarray Market Dynamics

• 3.1. Peptide Microarray Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Growing Burden of Chronic Diseases
    • 3.1.1.2. Technological Advancements In Diagnostic Testing
  • 3.1.2. Market Challenges
    • 3.1.2.1. Reimbursement Issues
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising Adoption for Peptide Microarrays

Chapter 4. Global Peptide Microarray Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Peptide Microarray Market, by Type

• 6.1. Market Snapshot
• 6.2. Global Peptide Microarray Market by Type, Performance - Potential Analysis
• 6.3. Global Peptide Microarray Market Estimates & Forecasts by Type 2019-2029 (USD Million)
• 6.4. Peptide Microarray Market, Sub Segment Analysis
  • 6.4.1. Instruments
  • 6.4.2. Reagents
  • 6.4.3. Services

Chapter 7. Global Peptide Microarray Market, by Application

• 7.1. Market Snapshot
• 7.2. Global Peptide Microarray Market by Application. Performance - Potential Analysis
• 7.3. Global Peptide Microarray Market Estimates & Forecasts by Application, 2019-2029 (USD Million)
• 7.4. Peptide Microarray Market, Sub Segment Analysis
  • 7.4.1. Disease Diagnostics
  • 7.4.2. Protein Functional Analysis
  • 7.4.3. Antibody Characterization
  • 7.4.4. Drug Discovery

Chapter 8. Global Peptide Microarray Market, by End-User

• 8.1. Market Snapshot
• 8.2. Global Peptide Microarray Market by End-User, Performance - Potential Analysis
• 8.3. Global Peptide Microarray Market Estimates & Forecasts by End-User 2019-2029 (USD Million)
• 8.4. Peptide Microarray Market, Sub Segment Analysis
  • 8.4.1. Pharmaceutical & Biotechnology Companies
  • 8.4.2. Hospitals & Clinics
  • 8.4.3. Diagnostic Centres
  • 8.4.4. Others

Chapter 9. Global Peptide Microarray Market, Regional Analysis

• 9.1. Peptide Microarray Market, Regional Market Snapshot
• 9.2. North America Peptide Microarray Market
  • 9.2.1. U.S. Peptide Microarray Market
    • 9.2.1.1. Type breakdown estimates & forecasts, 2019-2029
    • 9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
    • 9.2.1.3. End-User breakdown estimates & forecasts, 2019-2029
  • 9.2.2. Canada Peptide Microarray Market
• 9.3. Europe Peptide Microarray Market Snapshot
  • 9.3.1. U.K. Peptide Microarray Market
  • 9.3.2. Germany Peptide Microarray Market
  • 9.3.3. France Peptide Microarray Market
  • 9.3.4. Spain Peptide Microarray Market
  • 9.3.5. Italy Peptide Microarray Market
  • 9.3.6. Rest of Europe Peptide Microarray Market
• 9.4. Asia-Pacific Peptide Microarray Market Snapshot
  • 9.4.1. China Peptide Microarray Market
  • 9.4.2. India Peptide Microarray Market
  • 9.4.3. Japan Peptide Microarray Market
  • 9.4.4. Australia Peptide Microarray Market
  • 9.4.5. South Korea Peptide Microarray Market
  • 9.4.6. Rest of Asia Pacific Peptide Microarray Market
• 9.5. Latin America Peptide Microarray Market Snapshot
  • 9.5.1. Brazil Peptide Microarray Market
  • 9.5.2. Mexico Peptide Microarray Market
  • 9.5.3. Rest of Latin America Peptide Microarray Market
• 9.6. Rest of The World Peptide Microarray Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Pepperprint Gmbh
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Raybiotech Life, Inc.
  • 10.2.3. Creative Biolabs
  • 10.2.4. Aurora Instruments Ltd.
  • 10.2.5. Kinexus Bioinformatics Corporation
  • 10.2.6. Bio-Synthesis
  • 10.2.7. Microarrays Inc.
  • 10.2.8. Bio-Rad Laboratories
  • 10.2.9. Jpt Peptide Technologies
  • 10.2.10. Merck Kgaa

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption